ANDA 72418, held by Watson Pharmaceuticals. Amoxapine.
As of Nov 21, 2026, ANDA 72418 (Amoxapine), held by Watson Pharmaceuticals, was first approved by FDA on May 11, 1989, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amoxapine25MG · tablet;oral | Amoxapine | Discontinued |
| Jul 17, 2014 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 24, 2002 | Supplement 13Manufacturing | Approved | None posted |
| Oct 5, 2001 | Supplement 12Labeling | Approved | None posted |
| Sep 5, 2001 | Supplement 11Manufacturing | Approved | None posted |
| Nov 10, 1999 | Supplement 10Manufacturing | Approved | None posted |
| Aug 1, 1997 | Supplement 9Manufacturing | Approved | None posted |
| Dec 27, 1995 | Supplement 8Labeling | Approved | None posted |
| May 4, 1995 | Supplement 7Labeling | Approved | None posted |
| Oct 8, 1993 | Supplement 6Labeling | Approved | None posted |
| Oct 8, 1993 | Supplement 5Manufacturing | Approved | None posted |
| Jun 2, 1992 | Supplement 4Labeling | Approved | None posted |
| Jan 17, 1991 | Supplement 3Labeling | Approved | None posted |
| Jan 7, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Sep 12, 1989 | Supplement 1Labeling | Approved | None posted |
| May 11, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters